glp 1 with diverticulitis What is the risk of diverticular disease (diverticulosis or diverticulitis) associated GLP‑1 receptor agonist therapy in adults with type 2 diabetes? Tirzepatide and Diverticulitis: Safe Weight
Description
Afr Health Sci
Hold the needle in place for about 10 seconds to ensure the full dose is delivered
FDA.gov (accessed 26 July 2025)
These studies have demonstrated that Tirzepatide's combination of GLP and GIP promotes insulin sensitivity, appetite suppression, and cyclic adenosine monophosphate (cAMP) metabolism significantly better than administering either single agent (GLP or GIP)
However, discuss this specific scenario with your provider to establish a timing protocol that works for both medications
